MedTech Strategist Market Pathways: A Press Release

ARTICLE SUMMARY:

MedTech Strategist Market Pathways: Global Regulatory, Reimbursement, and Policy Review, launched June 2019, will be the go-to source to help industry make sense of the increasingly complex web of medical device market access policies worldwide.

Fairfield, CT:  MedTech Strategist, a leading information provider and investment conferences organizer focused exclusively on the rapidly evolving global medical device industry, is pleased to announce the launch of a new publication, MedTech Strategist Market Pathways: Global Regulatory, Reimbursement, and Policy Review.

altered MedTech Strategist Market Pathways will provide unparalleled intelligence on the global device and diagnostics regulatory and reimbursement environment, with insights from leading decision-makers, best practices from experts, analysis of key trends, and stories describing the strategies that product companies are using to address global regulatory and reimbursement issues to bring their products to market, all written by an editorial team with unparalleled experience covering the global medtech space.

Medical device companies – large and small – are facing an increasingly complex web of regulatory, reimbursement and other policy challenges worldwide. This rapidly changing landscape impacts companies’ ability to launch new technologies and to sustain them on the global market.

“Regulatory gatekeepers from around the world are crafting new approaches to oversight that can complicate a firm’s path to market.”

David Filmore

“Regulatory gatekeepers from around the world are crafting new approaches to oversight that can complicate a firm’s path to market. Meanwhile, reimbursement and market access hurdles continue to rise as public and private payers rethink strategies for incorporating medical technologies into healthcare systems,” said David Filmore, Executive Editor of MedTech Strategist Market Pathways, and former Executive Editor of The Gray Sheet. “While these changes bring challenges, they also create opportunities for those in the know.”

“While these changes bring challenges, they also create opportunities for those in the know.”

David Filmore

“MedTech Strategist takes great pride in being a part of the global medtech ecosystem through our publication and conferences. We are launching Market Pathways because we have heard from industry that there is a clear need for a high level, strategic information resource to address the increasingly complex market access challenges facing device companies worldwide. With Market Pathways, we look forward to providing that ecosystem with the same level of informed coverage from our unparalleled editorial team that our readers expect from a Medtech Strategist publication,” said Stephen Levin, co-Editor-in-Chief of MedTech Strategist Market Pathways.

Some questions that the new publication will address include:altered
  • What are the opportunities to leverage and pitfalls to watch for in FDA’s new pilots and programs?
  • Is there a path to success in Europe’s new regulatory environment?
  • How can you support reimbursement and market-access goals in clinical trials?
  • When should you consider value-based partnerships with payers and providers?
In the inaugural issue of MedTech Strategist Market Pathways, look for:

Key insights and updates on the impact of the pending new EU Medical Device Regulation on US and European companies; hear from top FDA device policymaker Jeffrey Shuren about the need for more agility at the agency; explore the US Medicare agency’s evolution on medtech innovation; and read about how one company developed a successful regulatory and reimbursement strategy to introduce its novel autonomous artificial intelligence diagnostic device. Also: global regulatory updates and key data points.

Additional information:

MedTech Strategist Market Pathways will complement the respected coverage provided in the company’s five-year-old flagship publication, MedTech Strategist, in which the company’s veteran editorial team covers disruptive device technologies, shifting competitive landscapes, innovative new marketplace dynamics, and changing business models.

Click here for more information and to receive a complimentary copy of the premier issue of MedTech Strategist Market Pathways. The publication is available as a single-user, multiple-user or enterprise-wide subscription, in online and print format. Special introductory annual subscription rates are available for a limited time; contact us to join our community today.


Regulatory & Reimbursement

Pathways’ Pick of the Week: Software at Center Stage

In this week's top news pick from MedTech Strategist Market Pathways: Europe unveils long-awaited guidance on how software fits into its new medical device and diagnostic regulatory schemes, just about two weeks after FDA issued related guidelines.

Read Article